CasNo.877399-52-5,High Purity Crizotinib CAS 877399-52-5 with Fast Shipment,(877399-52-5) Suppliers

1 Kilogram	FOB Price:USD 3.0000 -5.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : T/T,Other

Keywords

Crizotinib Crizotinib powder Crizotinib supplier

Quick Details

Appearance:white powder
Application:Medical use
PackAge:foil bag or as your requirement
ProductionCapacity:1000|Kilogram|Month
Storage:2-8°C
Transportation:By Express, by air, by sea

Superiority:

Hubei Yuanmeng Biological Technology Co., Ltd., which is located in Wuhan, China. We are specializing in the exportation of APIs, and plant extracts ect.

Our products has been exported to America, Australia, Brazil, the Europe, Middle East and other areas in the world. We have established close and stable cooperative relationships with over 200 domestic pharmaceutical and chemical enterprises. With high quality and favorable price, we′ re pleased to get your inquiry and we will reply you as soon as possible.

We will continue to forge ahead and strive hard for excellence, keep on exploring and progressing to develop more high-tech products with superior quality, to satisfy increasing demand of the clients, and create more value for our partners!

Details:

Crizotinib

Product Name: Crizotinib
CAS: 877399-52-5
MF: C21H22Cl2FN5O
MW: 450.34
EINECS: 638-814-9

Melting point: 192 °C
Boiling point: 599.2±50.0 °C
Density: 1.47±0.1 g/cm3
Storage temp.: room temp
Appearance: white to tan powder

Description:

Crizotinib is an oral ALK/ROS1/MET/RON inhibitor approved by the U.S. Food and Drug Administration. Crizotinib is not only used for the treatment of ALK- or ROS1-positive metastatic non-small cell lung cancer (NSCLC), but also for the treatment of adult and paediatric patients 1 year of age and older with unresectable, relapsed or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive interstitial myofibroblastic tumours (IMT).

Uses:

Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. In August 2011, the United States FDA approved crizotinib for the treatment of anaplastic lymphoma kinase (ALK) rearranged non-small-cell lung cancer (NSCLC).

Package Details:

Shipping Methods and Payment Ways:

Laboratory:

Warehouse:

Order Process and Tips:

Make an order	Please make clear what product and what quantity you need
Quote	Prices and Specification details would be offered for you to consider and confirm
Payment ways	Bank Transfer, , Money Gram, Bitcoin and USDT
Delivery ways	All Express Modes(EMS, DHL, TNT, FedEx, UPS, etc.)
Shipping address	Provide Valid and Correct destination address info(if possible with post code, phone number).
Packing	Select best ways according to quantity and safety degree(Super discreet, professional and experienced)
Lead time	Within 24 hours upon receipt of payment
Package picture	Photos of package would be offered to tell apart the items
Tracking number	Offered once it is released
Shipping time	around 15 days after receiving the payment
After-sale service	24/7 Online for any problems

Contact us!

Hubei Yuanmeng Biological Technology Co., Ltd.
Room 3820, Building 2, Vanke Golden City, Hongshan District, Wuhan, Hubei, China
Fiona Wei / Sales Manager